Marty J Duvall


Marty J Duvall was appointed as CEO in 2020.

Marty has extensive experience from executive leadership roles in drug development and commercialization within the global biotechnology and pharmaceutical industry, including a unique experience from the oncology and hematology sphere.

Prior to joining Oncopeptides Marty was Chief Executive Officer...

Roles at Oncopeptides AB

  • CEO

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.